• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Diasonics VP steps up to head ultrasound unit

Article

Bruce Moore, former vice president of marketing for the Diasonicsultrasound division, was named president of the division lastmonth. He was previously vice president of marketing for DiasonicsMRI. Moore returned to Diasonics--along with president and

Bruce Moore, former vice president of marketing for the Diasonicsultrasound division, was named president of the division lastmonth. He was previously vice president of marketing for DiasonicsMRI.

Moore returned to Diasonics--along with president and COO RoderickA. Young--following Toshiba's acquisition of the magnetic resonanceimaging business (SCAN 8/1/90). Young had initially taken on directresponsibility for the Diasonics ultrasound business.

A replacement for Moore as vice president of marketing forthe ultrasound division assumed his new responsibilities thisweek. William E. Richardson was formerly general manager of theinformation systems division of ADAC Laboratories.

While Diasonics improved the profitability of its businessessince the sale of the MRI division, ultrasound continued to lagbehind expectations last year (SCAN 2/13/91). Sales of the vendor'sSpectra high-end radiology ultrasound scanner should pick up nowthat a new color-flow Doppler architecture has been fully implemented,Moore said.

The vendor introduced its Spectra Plus color architecture atthe 1990 Radiological Society of North America meeting but didnot finish software revisions and begin demonstrating the packagein the field until last month, he said.

Diasonics' international ultrasound sales, through its Swisssubsidiary Sonotron, were strong last year despite the fact thatSpectra sales had not yet kicked in. Sonotron is expected to launcha Spectra product tailored to Europe this year.

Ultrasound sales should also get a boost from the incorporationof Diasonics' intravascular ultrasound system (IVUS) as an optionon Spectra. IVUS had been sold previously only as a stand-alonedevice. The IVUS option on Spectra will cost about $40,000, orless than half of what the stand-alone unit costs, Moore said.

Recent Videos
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Detecting PCa Recurrence in African Americans: Can 18F-Flotufolastat Have an Impact?
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Related Content
© 2024 MJH Life Sciences

All rights reserved.